ClinicalTrials.gg
CompletedNCT05300100IMOTUpdated Mar 24, 2023

Exploration of Sensory-motor Representations in Children of Typical Development Aged 5 to 8

An interventional study of sensorimotor activities in CHILD, sponsored by Centre Hospitalier de Lens. Completed at 5 sites in France. Open to participants aged 5 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-24.

Sponsored by Centre Hospitalier de Lens · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
5 Years to 8 Years
Sex
All
01

Study summary

Evaluate the quality of sensorimotor representations in typically developing children aged 5 to 8 years.

Read the detailed description

The early coupling of perception and action makes it possible to build the sensorimotor representations, necessary for the functions of anticipation, adaptation and learning which will allow a harmonious development of motor skills throughout ontogenesis. One of the current hypotheses to explain the learning disorders detected in elementary school is a defect in the development of sensorimotor representations. Our study therefore aims to assess the quality of sensorimotor representations in typically developing children aged 5 to 8 years, using a motor imaging protocol, conventionally used in the literature in adults and patients. child. This motor imagery protocol consists of comparing the time taken by the subject to perform a given action and the time taken to imagine the action he has just performed. More precisely, the mental chronometry paradigm, based on the similarity or the difference between the two durations, makes it possible to assess the robustness of sensorimotor representations. While this isochrony is widely reported in the literature in adults, developmental studies describe onset around 9-10 years of age. Currently there is a lack of data to know the construction of these sensorimotor representations in younger children, especially during the transition to primary school. The originality of our protocol lies in two points: 1. the proposed tasks are particularly suited to young children and 2. the subject himself times his performance in the two situations: action carried out and action imagined. The duration of the experience will last 1 hour per participant in a single session.

02

Conditions studied

  • CHILD
03

In context

Lead sponsor

Centre Hospitalier de Lens is the lead sponsor of 5 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child aged 5 to 8
  • Child enrolled in accordance with his age
  • No sensory abnormality identified
  • No neurodevelopmental abnormality identified

Exclusion criteria

Exclusion Criteria:

  • Child not affiliated to a social security scheme.
  • Refusal to participate by parents and / or child
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Activities

    The duration of the experience will last 1 hour per participant in a single session. The proposed actions were chosen from a very large sensorimotor repertoire of activities in everyday life for a child aged 5 to 8. The activities chosen involve either the whole body or specific parts such as the hand to grasp or perform graphic tests.

    Behavioral: sensorimotor activities

Interventions

  • Behavioralsensorimotor activities

    The activities chosen involve either the whole body or specific parts such as the hand to grasp or perform graphic tests. * Trial 1 : Straightening: passage from sitting to sitting. * Trial 2 : Movement with difficulty of balance: heel-toe walking * Trial 3 : Movement with difficulty of balance with a structured visual environment: heel-toe walk in a contrasting fabric decoration to increase the impact of visual flow * Trial 4 : Move to a target, 5 m away * Trial 5 : Graphics: drawing of a tree. This test requires spatial skills and the establishment of median space in written transcription. * Trial 6 : Manual entry: collection of 12 small cubes arranged in an arc in front of the child using one hand, the choice of which will be left to the child. All of these tests will be offered according to a so-called "interlaced" protocol, that is to say, each execution of an action will be followed by an action simulation, and this alternation will be repeated 5 times for each task. .

06

What researchers measure

Primary outcomes

  1. Evaluate the quality of sensorimotor representations in typically developing children aged 5 to 8 years.

    The primary outcome measure is the change in the gross motor imagery score. This is defined as the average of the motor imagery scores for each of the tasks performed individually; The motor imagery score for each individual IMtaskX task is calculated as follows: IMtaskX = \| (DrtaskX - DitaskX) / DrtaskX \| DrtaskX being the real measured duration of the movements performed DitaskX being the imagined duration of the movements performed Each task will be performed 5 times by each subject. DrtaskX and DitaskX are therefore an average of the 5 repetitions of the task. With regard to interpretation, the further the motor imagery index is from 0, the greater the difference between the duration of the imagined movement and the duration of the movement carried out, in other words the poorer the internal representations of the movement. 'action.

    Time frame: Day 1

Secondary outcomes

  1. Study the link between the construction of internal representations and overall sensorimotor skills according to age.

    Correlation between global motor imagery score and global MABC-II score by age. IMtaskX = \| (DrtaskX - DitaskX) / DrtaskX \| DrtaskX being the real measured duration of the movements performed DitaskX being the imagined duration of the movements performed

    Time frame: Day 1

  2. Study the link between the motor imagery score of each individual task and overall sensorimotor skills by age

    Correlation between the motor imagery score of each individual task and the overall MABC-II score by age. IMtaskX = \| (DrtaskX - DitaskX) / DrtaskX \| DrtaskX being the real measured duration of the movements performed DitaskX being the imagined duration of the movements performed

    Time frame: Day 1

  3. Study the link between the global motor imagery score, that is to say the construction of internal representations, and each of the 3 specific sensorimotor skills assessed via the MABC-II test according to age.

    Correlation between the global motor imagery score and the individual score of each of the 3 categories of the MABC-II test according to age. IMtaskX = \| (DrtaskX - DitaskX) / DrtaskX \| DrtaskX being the real measured duration of the movements performed DitaskX being the imagined duration of the movements performed

    Time frame: Day 1

  4. Study the link between the motor imagery score of each individual task and each of the 3 sensorimotor skills assessed via the MABC-II test according to age.

    Correlation between the motor imagery score of each individual task and the individual score of each of the 3 disciplines of the MABC-II test according to age.

    Time frame: Day 1

07

Study locations

5 sites
  • Psychomotor therapist' offices
    Amiens, 80000, France
  • Hospital Dr Schaffner
    Lens, 62307, France
  • Hôpital Saint Vincent
    Lille, 59000, France
  • Hospital Sambre Avesnois
    Maubeuge, 59600, France
  • Psychomotor therapist' offices
    Wavrin, 59136, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2022 to primary completion in Jan 2023, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2022
First posted
Mar 29, 2022
StartActual
Mar 4, 2022
Primary completionActual
Jan 27, 2023
CompletionActual
Jan 27, 2023
Last update
Mar 24, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05300100
Lead sponsor
Centre Hospitalier de Lens
Collaborators
Centre National de la Recherche Scientifique, France
Responsible party
Sponsor
First posted
Mar 29, 2022
Start date
Mar 4, 2022
Primary completion
Jan 27, 2023
Completion
Jan 27, 2023
Last update
Mar 24, 2023

Study contacts

Marie-Bertille DEHOUCK, Dr
principal investigator · Hospital of Lens

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion